RPL17 and neoplasm: Here, we present the 3rd case of a patient with advanced chordoma (in this case with negative PD-L1 expression and a low TMB in the original tumor specimen) treated with anti-PD1 antibodies and show that similar to the previous two cases, our patient also showed a good antitumor response (Figure 2).